Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

CD34 is crucial for skin tumor development in mice.

Stem cells help control the immune response to improve wound healing.

Myeloid cells can turn into skin and hair cells to help heal wounds.

Langerhans' cells are not involved in hair depigmentation in these mice.

Special cells can help regrow hair in alopecia areata.

Human thymus has stem cells that can self-renew and maintain their identity.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.

Enhancing Tregs can protect against alopecia areata.

HIV patients in Korea often have skin diseases like fungal infections, folliculitis, and seborrheic dermatitis, which are less common with effective HIV treatment.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Langerhans' cells are not responsible for depigmentation in this mouse model.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Small changes in cell division and differentiation can activate blood progenitors.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

PDCD4 is important for controlling skin cell growth and healing.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hematopoietic stem cell transplantation does not significantly affect COVID-19 severity in children with immune disorders.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.